Percent cellular tumor content reported by the TARGET investigators was not significantly different between the main cluster groups derived by the Global, RFS, or CR profiles, but was significantly lower in the EPIMMUNE derived cluster group containing the samples with methylation patterns associated with good response to PDL1 based immunotherapy (p = 0.005, Supplementary Table 5). Here, CD274 is linked to neoplasm.